Raymond James Financial Services Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$307K Buy
2024
Q2
Sell
2024
Q1
$345K Sell
2023
Q4
$461K Sell
2023
Q3
$340K Sell
2023
Q2
$558K Buy
2023
Q1
$328K Buy
2022
Q4
$222K Buy